Skip to main content
. 2012 May 2;33(7):1332–1339. doi: 10.1093/carcin/bgs158

Table I.

Distribution of baseline characteristics in nested case control studies of advanced colorectal adenoma and colorectal cancer in the PLCO Cancer Screening Trial

Adenoma Cancer
Characteristic Cases (n = 1205)a Controls (n = 1386)a Pb Cases (n = 364)a Controls (n = 394)a Pb
Age (years) 63.1±5.2 62.6±5.3 0.02 67.6±6.5 67.5±6.3 0.81
Sex, n (%) 0.83 0.71
  Male 776 (64.4) 887 (64.0) 216 (59.3) 239 (60.7)
  Female 429 (35.6) 499 (36.0) 148 (40.7) 155 (40.3)
Ethnicity, n (%) 0.23 0.97
  Non-Hispanic white 1136 (94.3) 1284 (92.6) 311 (90.9) 357 (90.6)
  Non-Hispanic black 29 (2.4) 46 (3.3) 18 (5.0) 21 (5.3)
  Other 40 (3.3) 56 (4.0) 15 (4.1) 16 (4.1)
First degree family history 
of colorectal cancer, n (%) 157 (13.1) 136 (9.9) 0.01 56 (15.6) 45 (11.6) 0.11
Smoking status, n (%)
  Never 462 (38.4) 657 (47.4) <0.01 157 (43.1) 164 (41.6) 0.90
  Former cigarette smoker 165 (13.7) 94 (6.8) 167 (45.9) 187 (47.5)
  Current cigarette smoker 577 (47.9) 635 (45.8) 40 (11.0) 43 (10.9)
B[a]P (ng/day)
  median (IQR) 7.0 (1.3, 36.1) 6.9 (1.2, 35.9) 0.17 5.5 (1.2. 23.8) 5.4 (1.0, 36.4) 0.74
PhIP (ng/day)
  Median (IQR) 65.4 (24.6, 132.6) 61.1 (23.3, 132.3) 0.69 50.0 (21.0. 127.5) 53.8 (22.8, 135.8) 0.23
MeIQx (ng/day)
  Median (IQR) 22.7 (9.75, 43.2) 20.5 (8.94, 41.8) 0.20 18.0 (9.1. 38.7) 18.9 (9.0, 39.6) 0.59
DiMeIQx (ng/day)
  Median (IQR) 1.02 (0.23, 2.47) 0.95 (0.27, 2.2) 0.39 0.80 (0.18, 2.22) 0.90 (0.22, 2.22) 0.35
Combined nitrate and nitrite 
(ng/day)
  Median (IQR) 0.32 (0.13, 0.61) 0.28 (0.12, 0.59) 0.10 0.31 (0.13, 0.61) 0.28 (0.12, 0.55) 0.36

Data are means ± standard deviations unless otherwise indicated. IQR, Interquartile range; NSAIDs, non-steroidal anti-inflammatory drugs.

aNumbers may not sum due to total due to missing values.

b P-values derived from t-test or chi-square test.